1. Home
  2. RYTM vs GTES Comparison

RYTM vs GTES Comparison

Compare RYTM & GTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$93.66

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Gates Industrial Corporation plc

GTES

Gates Industrial Corporation plc

HOLD

Current Price

$27.28

Market Cap

6.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYTM
GTES
Founded
2008
1911
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.2B
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
RYTM
GTES
Price
$93.66
$27.28
Analyst Decision
Strong Buy
Buy
Analyst Count
14
9
Target Price
$131.14
$28.56
AVG Volume (30 Days)
555.5K
1.8M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
28.34
29.73
EPS
N/A
0.23
Revenue
N/A
N/A
Revenue This Year
$55.34
$5.83
Revenue Next Year
$86.06
$3.95
P/E Ratio
N/A
$120.43
Revenue Growth
N/A
N/A
52 Week Low
$60.99
$20.88
52 Week High
$122.20
$28.47

Technical Indicators

Market Signals
Indicator
RYTM
GTES
Relative Strength Index (RSI) 62.82 60.43
Support Level $82.43 $21.45
Resistance Level $100.69 $28.43
Average True Range (ATR) 4.46 0.89
MACD 0.64 0.17
Stochastic Oscillator 81.49 66.80

Price Performance

Historical Comparison
RYTM
GTES

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

About GTES Gates Industrial Corporation plc

Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.

Share on Social Networks: